Ask your AI about this

Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:

Connect your AI · Plans and the 7-day free trial (card required)

Holdings, Q3 2026

Largest first. Common shares only.

Latest 13F holdings
#The fund's own figures at the end of the quarter. A report can be up to 45 days old when it is filed. Options and bonds are not counted here.Filing
1WVE
Wave Life Sciences, Inc.
4.59M$17.0M47.1%New13F ↗
2IVVD
Invivyd, Inc.
9.25M$8.0M22.3%Unchanged13F ↗
3TGTX
TG Therapeutics, Inc.
88,354$4.9M13.7%Unchanged13F ↗
4ARWR
Arrowhead Pharmaceuticals, Inc.
36,851$2.4M6.7%Unchanged13F ↗
5SLN
Silence Therapeutics Plc · ADR
101,203$1.1M3.1%Unchanged13F ↗
6Fractyl Health Inc1.86M$1.0M2.8%Unchanged13F ↗
7PRQR
ProQR Therapeutics N.V. · Shs Euro
599,793$995.7K2.8%Unchanged13F ↗
8RCKT
Rocket Pharmaceuticals, Inc.
210,871$554.6K1.5%Unchanged13F ↗
9CRIS
Curis, Inc.
14,244$12.0K<0.1%New13F ↗

Changes since Q2 2026

2 new, 0 added to, 0 trimmed, 2 exited, 7 unchanged. By estimated dollars.

New positions (2)

New positions
WVE
Wave Life Sciences, Inc.
4.59MNew$17.0M
CRIS
Curis, Inc.
14,244New$12.0K

Added to (0)

None this quarter.

Trimmed (0)

None this quarter.

Exited (2)

Exited
Wave Life Sciences Ltd4.59MExited-$26.7M
Curis Inc284,889Exited-$148.7K

The 10 largest of each, by estimated dollars: shares changed times the later report's price. Index tracking, splits and mergers move positions too.

Compare two quarters

Pick any two quarters: what is new, added to, trimmed or exited. Premium plan.

Reported value by quarter

Value and number of positions at the end of each quarter.

Loading…

Largest positions in earlier quarters

Pick a quarter to see what the fund's biggest positions were then.

Loading…

Ten largest positions

By value, Q3 2026.

$0$5.0M$10.0M$15.0M$20.0MWVE · Value: $16,976,651WVEIVVD · Value: $8,046,902IVVDTGTX · Value: $4,928,386TGTXARWR · Value: $2,411,898ARWRSLN · Value: $1,106,149SLNFractyl… · Value: $1,010,470Fractyl…PRQR · Value: $995,656PRQRRCKT · Value: $554,591RCKTCRIS · Value: $11,951CRIS

Filings

13F filings
Filing
Q3 2026Nov 13, 202613F-HR9$36.0MCurrentSEC ↗
Q2 2026Aug 13, 202613F-HR9$47.2MCurrentSEC ↗
Q1 2026May 14, 202613F-HR9$53.8MCurrentSEC ↗
Q4 2025Feb 13, 202613F-HR9$137.6MCurrentSEC ↗
Q3 2025Nov 13, 202513F-HR9$68.0MCurrentSEC ↗
Q2 2025Aug 13, 202513F-HR9$58.6MCurrentSEC ↗
Q1 2025May 14, 202513F-HR11$73.0MCurrentSEC ↗

Most recent first, up to 80. An amendment can replace a report or add holdings to it. All 13F filings

Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer